Formulation & Delivery 2024

25 - 26 April 2024 | London, UK

Connect with leading experts to explore strategic advances in formulation, drug delivery, RNA, and inhaled therapies.

Presentation Speaker
Overview Formulation & Drug Delivery Inhalation & Respiratory Drug Delivery RNA Therapeutics & Delivery

Dive Into Formulation & Delivery 2024: Explore Innovations in Formulation, Drug Delivery, RNA & Inhaled Therapeutics. 

Join 400+ leaders, experts and researchers at Formulation & Delivery 2024, connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in pharmaceutical drugs formulation, drug delivery, inhaled therapeutics & RNA development.

Formulation & Delivery 2024 features our ever-popular 10th Annual Formulation & Delivery Congress, 9th Annual Inhalation & Respiratory Drug Delivery Congress and 2nd Annual RNA Therapeutics & Delivery Congress and is attended by over 400 senior level experts in London to network, debate and discuss the industry’s pressing challenges & opportunities; fostering partnerships & collaborations in this field. Do not miss out on attending this event to stay at the forefront of the research – from innovation in small & large molecule drugs formulation, through to inhaled biologics, novel drug delivery systems and advances in RNA chemistry & therapeutics development.

10th Annual Formulation & Drug Delivery Congress

Join market-leading drug development professionals for high-level discussions on the latest innovations in formulation science and drug delivery. This must attend event will discuss the current state of the industry, looking at new strategies for enhancing biopharmaceutical formulations with AI as well as highlighting key updates in oral delivery of biologics and patient-centric approaches. Featuring a track on drug stability, characterization, and developability, the congress emphasizes advances in protein aggregation preventions and optimization of lyophilization strategies. 

Leading expert scientists working across formulation, drug delivery, bioanalysis, developability, and manufacturing science & technologies, representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic institutions. 

Over 50 technical presentations and case studies focused on the critical topics in AI for automated formulations, enhanced drug delivery through vaccines, PROTAC, and exosomes, as well as an exploration of sustainable drug development.

Agenda at a Glance


Day One | Track 1: Small Molecule Drug Formulation

Day One | Track 2: Biologics Drug Delivery

Day One | Track 3: Bioanalysis: Stability, Characterisation, Developability 

Day Two | Track 1: Small Molecule Drug Delivery

Day Two | Track 2: Biologics & New Modalities Drug Formulation

9th Annual Inhalation & Respiratory Drug Delivery Congress

Explore the forefront of inhaled therapies and delve into the novel formulations and delivery methods revolutionising respiratory treatments. Two comprehensive tracks will spotlight industry developments, covering inhaled biologics, particle engineering breakthroughs, diverse therapeutic case studies, and novel device development approaches. Participate in workshops, panels, and roundtable discussions to pioneer advancements in the field and stay at the forefront of innovation. 

Leading experts in inhalation, respiratory and nasal drug development & delivery science representing global pharmaceutical organisations, leading biotechnology companies and internationally renowned academic and research organisations.

Over 15 presentations and case studies focusing on the emerging therapies and key issues in inhalation and respiratory drug development as well as the latest developments in inhalation devices and digital & connected health.

Agenda at a Glance


Day One | Track 4: Formulation Development For Inhaled Therapies

Day Two | Track 3: Application Areas of Inhaled Therapies, Delivery & Device Development

2nd Annual RNA Therapeutics & Delivery Congress

Gain insights into the latest development, formulation and delivery of RNA therapeutics. Learn from key opinion leaders working to deliver RNA therapies for several therapeutic areas including infectious disease and cardiovascular disease. Across two in-depth sessions the latest improvements pushing the industry forward will be addressed: from mRNA characterisation, RNA delivery agents and viral vectors through to novel RNA drug discovery tools and RNAs as drug targets. Stay at the forefront of the growing interest in technologies including mRNA vaccines, siRNA as well as antisense and RNA interference.

Discuss the latest innovations in RNA chemistry & formulation strategies. Presentations will delve into developing new strategies to design these therapeutics, as well as scale up & manufacturing considerations and exploring the latest developments in delivery therapies outside the liver  

Discover collaborative solutions to RNA delivery strategies. Delve into viral vector and non-viral techniques as well as new approaches which target outside the liver 

Take a deep dive into RNA therapeutics case studies & commercialization strategies: from some of the leading RNA therapeutic companies including Sixfold Bioscience, Altamira Therapeutics, TransCode Therapeutics  

Agenda at a Glance


Day One | Track 1: RNA Formulation Strategies, Design & Development

Day Two | Track 1: RNA Drug Delivery

What to Expect

400

leading pharma, biotech, & academic delegates

28
hours of presentations, discussions & interactive content
9
hours of networking breaks, including speed networking & refreshments
110
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 75 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Formulation & Delivery 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Declan Lowney
Director of Stability Sciences,,
Janssen R&D
Kajsa Rådevik
Associate Director CMC Regulatory Affairs,
AstraZeneca
Sam Lai
CSO,
Inhalon Biopharma

All Speakers

Alexander Kros
Professor,
University of Leiden
Alexander Russell
Associate Director,
AbbVie
Amal Ali Elkordy
Professor of Pharmaceutics,
University of Sunderland
Andrew Feilden
Director Analytical Science,
Bicycle TX
Annette Heydenreich
Principal Scientist,
Symphogen A/S
Asif Ahmed
Founder & Executive Chairman,
MirZyme Therapeutics Limited
Ben Forbes
Professor of Pharmaceutics,
King's College London
Bin Yang
Senior Scientist,
AstraZeneca
Cees Van Rijn
Professor,
University of Amsterdam
Charley Wu
Professor of Chemical Engineering,
University of Surrey
Chris Broomell
Director, Head of Analytical Development,
Omega Therapeutics
Christopher Locher
CEO,
Versatope Therapeutics, Incorporated
Claus-Michael Lehr
Professor,
University of Saarland
Covadonga Paneda
Chief Operating Officer,
Altamiratherapeutics
Dan Bach Kristensen
Scientific Director,
Symphogen
Daniel Tondera
Head of Biology,
Pantherna Therapeutics GmbH
David Cook
CSO,
Blueberry Therapeutics
Derek O'Hagan
Senior Advisor, Senior Fellow,
GSK Vaccines
Elena Sanna
Associate Principal Scientist,
Sixfold Bioscience
Elizabeth Ogden
Process Engineer,
AstraZeneca
Estelle Beguin
Director Technology Research,
Ethris GmbH
Hyunhong James Min
Senior Scientist,
Pfizer Ltd
Ijeoma Uchegbu
Professor,
University College London
Ildikó Terebesi
Managing Director,
INVITE
Janis Shute
Scientific Director,
University of Portsmouth
Jens Twellmeyer
Associate Director Science & Technology,
Novartis
Jérôme Mantanus
Head of Materials Science,
UCB Pharma
Jonathan Reid
Professor of Physical Chemistry and Director of the EPSRC Centre for Doctoral Training in Aerosol Science,
University of Bristol
Jose Paulo Lorenzo
Senior Scientist,
Panosome
Juha Monkare
Senior Scientist,
J&J Innovative Medicine
Juha Monkare
Senior Scientist,
J&J Innovative Medicine
Kamalinder K Singh
Professor of Pharmaceutical Technology and Drug delivery,
University of Central Lancshire
Koen Raemdonck
Full Professor,
Ghent University
Lorraine O'Driscoll
Professor of Pharmacology & Biomedicine, Pharmacy,
Trinity College Dublin
Luis Padrela
Associate Professor,
SSPC research Centre, Bernal Institute
Mahnoush Bahjat
Associate Director,
AatraZeneca
Majella Lane
Director Skin Research Group,
UCL School of Pharmacy
Martinus Capelle
Scientific Director,
Johnson & Johnson
Maurits Kleijnen
Head of Research,
Intract Pharma
Meike Harms
Lead Scientist,
Merck Healthcare KGaA
Nagy Habib
Lead Clinician and Head of the Department,
Imperial College London
Naila El Kechai
Head of Biologics Formulation and Process development section,
Sanofi
Nathalie Wauthoz
Professor,
Universite Libre de Bruxelles
Paul Marshall
Regulatory Affairs Director,
Jazz Pharmaceuticals
Per-Olof Wahlund
Specialist,
Novo Nordisk A/S
Philip Rye
Chief Scientific Officer,
AlgiPharma AS
Richard Storey
Materials Scientist,
AstraZeneca
Rikke Dueholm
Senior Scientist,
AstraZeneca
Sam Nash
Associate Principal Scientist,
AstraZeneca
Shayoni Dutta
principal data scientist,
GSK
Simone Vecchi
Associate Director DP Development,
Janssen
Sophie Tourdot
Immunogenicity Sciences Lead,
Pfizer Inc.
Sophie Janbon
Director,
AstraZeneca
Stephen Pham
Senior Vice President,
Avalyn Pharma Inc.
Sune Andersen
Associate Director/Principal Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson
Supriyadi Hafiz
Senior Scientist,
Merck Life Science KGaA
Thomas von Erlach
Chief Scientific Officer,
Vivtex
Tjasa Vrlinic
principal investigator,
Medincell
Venkatesh Teja Banala
Biopharmaceutics Investigator,
GSK
Vincent Ling
Senior Director,
Takeda Pharmaceuticals
Vineeta Tripathi
CEO,
Vitarka Therapeutics Ltd
Yngve Mikkelsen
CMO,
AlgiPharma AS
Yogeshwar Bachhav
Director (Consultant),
AiCuris Anti-infective Cures AG

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Beyond the Needle: Exploring the Potential of an Inhaled TB Vaccine

Research efforts aim to investigate whether an inhaled version of the tuberculosis (TB) vaccine, Bacille Calmette-Guérin (BCG) is more effective than the traditional intradermal method of delivery.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Advancements in Inhaled Gene Therapy for Pulmonary Conditions

Delve into the specifics of inhaled gene therapy, its mechanisms, applications, and future prospects, it's essential to appreciate the foundational principles of gene therapy that paved the way for these advancements.

Plan Your Visit

Novotel London West

1 Shortlands,
Hammersmith International Ctre,
London, W6 8DR

Just minutes from three of London's main tube lines (Piccadilly, District and Hammersmith & City) and located in the heart of Hammersmith; Novotel London West is ideally located for trips to Westfield London, Harrods & Kensington High Street. Also conveniently located to Heathrow Airport with excellent road and rail links to the rest of the UK. This large and modern hotel offers on-site parking (chargeable), fitness suite and complimentary Wi-Fi throughout.

By Air

London Heathrow Airport - Novotel London West is accessible from Heathrow via the Underground on the Piccadilly Line – fares cost around £5 into Central London. A taxi from the airport will take approximately 20 minutes and will cost around £30 - £40.

London Gatwick Airport - The Gatwick Express runs every 15 mins - take it to Victoria station, and then get the District line to Hammersmith (about 15 mins). A taxi from the airport will take around 60 mins and cost between £65 - £80.

By Underground & Bus

Hammersmith Underground Station is adjacent to the hotel (3 minutes walk) with access to the Piccadilly, District and Hammersmith & City Lines. When exiting Hammersmith station, turn right and walk across the bus station. Cross over the roads using the island and keep on the right-hand side of Hammersmith Road. Continuing walking for 2 mins, and the hotel is accessible via stone steps.

For buses in central London, take route numbers 9 and 10. The main coach station (London Hammersmith) is 3 minutes walk away.

By Rail

The closest National Rail train station is Kensington Olympia (20 minutes walk).

By Car

Leave the A4 at the Hammersmith turning and proceed along Hammersmith Bridge Road to the large roundabout underneath the flyover. Take the fifth exit off the roundabout. Then turn left into Shortlands - the main hotel entrance and parking will be on your left-hand side.

Parking

Novotel London West offers over 240 on-site car parking spaces (charged per hour for residents parking). For further information including a map and full directions, please visit: www.novotel.com/gb/hotel-0737-novotel-london-west/index.shtml

Oxford Global have secured a number of bedrooms at Novotel London West at a reduced rate:

Wednesday 24th April 2024 – £190 including VAT and breakfast


Thursday 25th April 2024 – £190 including VAT and breakfast

*Please note: £10 supplement is applicable for double occupancy

Should you wish to book a room, please email help@oxfordglobal.com. The final cut-off date to book bedrooms is Thursday 28th March 2024 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to cancellation charges.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Formulation & Delivery 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch